|
1
|
Virdis A and Schiffrin EL: Vascular
inflammation: A role in vascular disease in hypertension? Curr Opin
Nephrol Hypertens. 12:181–187. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tedgui A and Mallat Z: Anti-inflammatory
mechanisms in the vascular wall. Circ Res. 88:877–887. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Taube A, Schlich R, Sell H, Eckardt K and
Eckel J: Inflammation and metabolic dysfunction: Links to
cardiovascular diseases. Am J Physiol Heart Circ Physiol.
302:H2148–H2165. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schenkein HA and Loos BG: Inflammatory
mechanisms linking periodontal diseases to cardiovascular diseases.
J Clin Periodontol. 40 Suppl 14:S51–S69. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ait-Oufella H, Taleb S, Mallat Z and
Tedgui A: Recent advances on the role of cytokines in
atherosclerosis. Arterioscler Thromb Vasc Biol. 31:969–979. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xiao JR, Do CW and To CH: Potential
therapeutic effects of baicalein, baicalin, and wogonin in ocular
disorders. J Ocul Pharmacol Ther. 30:605–614. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee W, Ku SK and Bae JS: Anti-inflammatory
effects of Baicalin, Baicalein, and Wogonin in vitro and in vivo.
Inflammation. 38:110–125. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao Y, Yao J, Wu XP, Zhao L, Zhou YX,
Zhang Y, You QD, Guo QL and Lu N: Wogonin suppresses human alveolar
adenocarcinoma cell A549 migration in inflammatory microenvironment
by modulating the IL-6/STAT3 signaling pathway. Mol Carcinog. 54
Suppl 1:E81–E93. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee YM, Cheng PY, Chen SY, Chung MT and
Sheu JR: Wogonin suppresses arrhythmias, inflammatory responses,
and apoptosis induced by myocardial ischemia/reperfusion in rats. J
Cardiovasc Pharmacol. 58:133–142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen S, Xiong J, Zhan Y, Liu W and Wang X:
Wogonin inhibits LPS-induced inflammatory responses in rat dorsal
root ganglion neurons via inhibiting TLR4-MyD88-TAK1-mediated NF-κB
and MAPK signaling pathway. Cell Mol Neurobiol. 35:523–531. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen LG, Hung LY, Tsai KW, Pan YS, Tsai
YD, Li YZ and Liu YW: Wogonin, a bioactive flavonoid in herbal tea,
inhibits inflammatory cyclooxygenase-2 gene expression in human
lung epithelial cancer cells. Mol Nutr Food Res. 52:1349–1357.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen YC, Shen SC, Lee WR, Lin HY, Ko CH,
Shih CM and Yang LL: Wogonin and fisetin induction of apoptosis
through activation of caspase 3 cascade and alternative expression
of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch
Toxicol. 76:351–359. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee WR, Shen SC, Lin HY, Hou WC, Yang LL
and Chen YC: Wogonin and fisetin induce apoptosis in human
promyeloleukemic cells, accompanied by a decrease of reactive
oxygen species, and activation of caspase 3 and
Ca2+-dependent endonuclease. Biochem Pharmacol.
63:225–236. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li DR, Hou HX, Zhang W and Li L: Effects
of wogonin on inducing apoptosis of human ovarian cancer A2780
cells and telomerase activity. Ai Zheng. 22:801–805.
2003.PubMed/NCBI
|
|
15
|
Wang W, Guo QL, You QD, Zhang K, Yang Y,
Yu J, Liu W, Zhao L, Gu HY, Hu Y, et al: The anticancer activities
of wogonin in murine sarcoma S180 both in vitro and in vivo. Biol
Pharm Bull. 29:1132–1137. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin CC, Kuo CL, Lee MH, Lai KC, Lin JP,
Yang JS, Yu CS, Lu CC, Chiang JH, Chueh FS, et al: Wogonin triggers
apoptosis in human osteosarcoma U-2 OS cells through the
endoplasmic reticulum stress, mitochondrial dysfunction and
caspase-3-dependent signaling pathways. Int J Oncol. 39:217–224.
2011.PubMed/NCBI
|
|
17
|
Lee JY and Park W: Anti-Inflammatory
effect of wogonin on RAW 264.7 mouse macrophages induced with
polyinosinic-polycytidylic acid. Molecules. 20:6888–6900. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wakabayashi I and Yasui K: Wogonin
inhibits inducible prostaglandin E2 production in
macrophages. Eur J Pharmacol. 406:477–481. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shieh DE, Liu LT and Lin CC: Antioxidant
and free radical scavenging effects of baicalein, baicalin and
wogonin. Anticancer Res. 20:2861–2865. 2000.PubMed/NCBI
|
|
20
|
Lim BO: Efficacy of wogonin in the
production of immunoglobulins and cytokines by mesenteric lymph
node lymphocytes in mouse colitis induced with dextran sulfate
sodium. Biosci Biotechnol Biochem. 68:2505–2511. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chi YS, Lim H, Park H and Kim HP: Effects
of wogonin, a plant flavone from Scutellaria radix, on skin
inflammation: In vivo regulation of inflammation-associated gene
expression. Biochem Pharmacol. 66:1271–1278. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yao J, Pan D, Zhao Y, Zhao L, Sun J, Wang
Y, You QD, Xi T, Guo QL and Lu N: Wogonin prevents
lipopolysaccharide-induced acute lung injury and inflammation in
mice via peroxisome proliferator-activated receptor gamma-mediated
attenuation of the nuclear factor-κB pathway. Immunology.
143:241–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cohen-Sela E, Chorny M, Koroukhov N,
Danenberg HD and Golomb G: A new double emulsion solvent diffusion
technique for encapsulating hydrophilic molecules in PLGA
nanoparticles. J Control Release. 133:90–95. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ozcelikay AT, Pekiner C, Ari N, Ozturk Y,
Ozuari A and Altan VM: The effect of vanadyl treatment on vascular
responsiveness of streptozotocin-diabetic rats. Diabetologia.
37:572–578. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nasri S, Roghani M, Baluchnejadmojarad T,
Rabani T and Balvardi M: Vascular mechanisms of
cyanidin-3-glucoside response in streptozotocin-diabetic rats.
Pathophysiology. 18:273–278. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Weischenfeldt J and Porse B: Bone
marrow-derived macrophages (BMM): Isolation and applications. CSH
Protoc 2008. 2008.
|
|
27
|
Huang AY, Golumbek P, Ahmadzadeh M, Jaffee
E, Pardoll D and Levitsky H: Role of bone marrow-derived cells in
presenting MHC class I-restricted tumor antigens. Science.
264:961–965. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim S, Lee Y, Park H, Hong D, Khang G and
Lee D: Reduced inflammatory responses to poly(lactic-co-glycolic
acid) by the incorporation of hydroxybenzyl alcohol releasing
polyoxalate. Macromol Res. 19:1242–1249. 2011. View Article : Google Scholar
|
|
29
|
Nicolete R, dos Santos DF and Faccioli LH:
The uptake of PLGA micro or nanoparticles by macrophages provokes
distinct in vitro inflammatory response. Int Immunopharmacol.
11:1557–1563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dinh QN, Drummond GR, Sobey CG and
Chrissobolis S: Roles of inflammation, oxidative stress, and
vascular dysfunction in hypertension. Biomed Res Int.
2014:4069602014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Martinez FO and Gordon S: The M1 and M2
paradigm of macrophage activation: Time for reassessment.
F1000Prime Rep. 6:132014. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Italiani P and Boraschi D: From monocytes
to M1/M2 macrophages: Phenotypical vs. functional differentiation.
Front Immunol. 5:5142014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Graziano F, Vicenzi E and Poli G: Plastic
restriction of HIV-1 replication in human macrophages derived from
M1/M2 polarized monocytes. J Leukoc Biol. 100:1147–1153. 2016.
View Article : Google Scholar : PubMed/NCBI
|
